SynthesisAsian Pacific journal of cancer prevention : APJCP2025
Personalised Approach in Oncology to Improve the Efficiency of Patient Diagnosis and Treatment.
Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to identify the main directions and recent advancements in personalised approaches to cancer diagnosis and treatment, based on a comprehensive analysis of current clinical and technological practices.
methodsThe study employed a systematic literature review of 62 peer-reviewed publications from 2019-2025 across major scientific databases, using predefined inclusion and exclusion criteria.
resultsAccording to the analysis, the most promising diagnostic tools in personalised oncology are liquid biopsy, next-generation sequencing, and omics technologies like proteomics and metabolomics. These tools allow for molecular characterisation, early detection, and dynamic monitoring of tumour progression and response to treatment. Targeted therapy, immunotherapy, and genomic approaches showed the most promise for personalised cancer treatment among therapeutic approaches, especially when aided by pharmacogenomics and molecular profiling. It was discovered that combining artificial intelligence with imaging modalities improves outcome prediction, treatment planning, and diagnostic accuracy. The results highlight how crucial it is to integrate therapeutic and diagnostic advancements to enhance clinical judgement, patient outcomes, and the overall effectiveness of oncology healthcare.
conclusionAccording to the study's findings, applying individualised therapeutic approaches in combination with genomic, proteomic, metabolomic, and imaging technologies greatly improves the accuracy, efficacy, and safety of cancer diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.